Genomic Tumor Board ECHO
December 2023 - November 2024
The American Cancer Society in collaboration with the Jackson Laboratory, has developed an ECHO program to address the need for innovative ways to lessen the treatment gap between community oncology care and medical center-level care. The goal of these program is to work together to provide interpretation support for clinicians and engage community oncologists in a robust discussion of treatment options for the patient and evaluate actionable results. We encourage multidisciplinary teams of medical oncologists, pathologists, surgeons, genetic counselors, pharmacists, radiologists, basic scientists, medical students, residents, nurses, clinical trial and genomic testing experts to join.
Our Experts

Christine Walko, Pharm.D.
Precision Medicine Team Lead
Precision Medicine Clinical Service Attending

Todd Knepper, Pharm.D.
Precision Medicine Clinical Service Attending

Jens Rueter, MD
Medical Director, MCGI

Kate Reed MPH, ScM, CGC

Leah Graham, PhD

Lindsey Kelley, MPH, CGC

Susan Halverson

Kara K. Landry, MD
Co-Director Cancer Genetics and Prevention Program